It is also possible that excess weight itself is correlated to lower bone mass in young age, thus causing weaker osteoclast activity and lower counteracting levels of OPG [28], or that obesity induces decreased osteoblast production of OPG through hormonal paths, perhaps through leptin-mediated actions [30]. Here, TNFRSF11B is linked to obesity due to melanocortin 4 receptor deficiency.